Online first
Research paper
Published online: 2024-11-12

open access

Page views 170
Article views/downloads 96
Get Citation

Connect on Social Media

Connect on Social Media

Cardiovascular profile score (CVPS) and selected cardiac parameters in fetuses with Vein of Galen Malformation

Aleksandra Juras1, Tomasz Wloch, Wojciech Cnota1, Agata Wloch1

Abstract

Objectives: Vein of Galen Malformation (VGAM) is a rare congenital cerebrovascular anomaly. Early detection and monitoring of concurrent fetal heart failure in VGAM are crucial for improving outcomes.

The study aims to evaluate heart anatomy, systolic and diastolic heart function, and indicators of heart failure in fetuses referred to a tertiary center due to VGAM detected in the second or third trimester.

Material and methods: This single-center retrospective study of echocardiographic data from five fetuses with VGAM examined between 2008 and 2023. Parameters analyzed included gestational age, reason for referral, cardiovascular profile score (CVPS), systolic and diastolic heart function and selected cardiac parameters

Results: Cardiomegaly as a sign of congestive heart failure was the main reason for referral most of the fetuses (4/5 — 80%) diagnosed later as VGAM in our center. Abnormal cerebral vessel flow was visualized in all cases, with normal umbilical arterial flow. Three fetuses were treated prenatally with digoxin due to congestive heart failure. Monophasic tricuspid valve inflow and decreased shortening fraction (SF) were observed in three fetuses (60%) at the time of diagnosis. CVPS scores ranged from 2 to 10, correlating with the severity of cardiac compromise. All five patients demised, three died in utero, and two shortly after birth.

Conclusions: This study emphasizes the severe cardiac implications of VGAM detected in utero and the need for early and comprehensive fetal assessment. Despite early diagnosis, outcomes remain poor, necessitating further research into effective prenatal treatments and management protocols to enhance survival for affected fetuses.

Article available in PDF format

View PDF Download PDF file

References

  1. Frawley GP, Dargaville PA, Mitchell PJ, et al. Clinical course and medical management of neonates with severe cardiac failure related to vein of Galen malformation. Arch Dis Child Fetal Neonatal Ed. 2002; 87(2): F144–F149.
  2. Brevis Nuñez F, Dohna-Schwake C. Epidemiology, diagnostics, and management of vein of galen malformation. Pediatr Neurol. 2021; 119: 50–55.
  3. Taffin H, Maurey H, Ozanne A, et al. Long-term outcome of vein of Galen malformation. Dev Med Child Neurol. 2020; 62(6): 729–734.
  4. Deloison B, Chalouhi GE, Sonigo P, et al. Hidden mortality of prenatally diagnosed vein of Galen aneurysmal malformation: retrospective study and review of the literature. Ultrasound Obstet Gynecol. 2012; 40(6): 652–658.
  5. Paladini D, Deloison B, Rossi A, et al. Vein of Galen aneurysmal malformation (VGAM) in the fetus: retrospective analysis of perinatal prognostic indicators in a two-center series of 49 cases. Ultrasound Obstet Gynecol. 2017; 50(2): 192–199.
  6. D'Amico A, Tinari S, D'Antonio F, et al. Outcome of fetal Vein Galen aneurysmal malformations: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2022; 35(25): 5312–5317.
  7. Gillet de Thorey A, Ozanne A, Melki J, et al. State of the art of antenatal diagnosis and management of vein of Galen aneurysmal malformations. Prenat Diagn. 2022; 42(9): 1073–1080.
  8. Godfrey ME, Tworetzky W, Morash D, et al. Cardiac Findings in the Fetus with Cerebral Arteriovenous Malformation Are Associated with Adverse Outcome. Fetal Diagn Ther. 2017; 41(2): 108–114.
  9. Van Mieghem T, Gucciardo L, Lewi P, et al. Validation of the fetal myocardial performance index in the second and third trimesters of gestation. Ultrasound Obstet Gynecol. 2009; 33(1): 58–63.
  10. Huhta JC. Fetal congestive heart failure. Semin Fetal Neonatal Med. 2005; 10(6): 542–552.
  11. Komiyama M. The median vein of prosencephalon of Markowski: From morphology to genetics. Interv Neuroradiol. 2020; 26(6): 752–756.
  12. Zhao S, Mekbib KY, van der Ent MA, et al. Mutation of key signaling regulators of cerebrovascular development in vein of Galen malformations. Nat Commun. 2023; 14(1): 7452.
  13. Vivanti A, Ozanne A, Grondin C, et al. Loss of function mutations in EPHB4 are responsible for vein of Galen aneurysmal malformation. Brain. 2018; 141(4): 979–988.
  14. Hartung J, Heling KS, Rake A, et al. Detection of an aneurysm of the vein of Galen following signs of cardiac overload in a 22-week old fetus. Prenat Diagn. 2003; 23(11): 901–903.
  15. Buratti S, Mallamaci M, Tuo G, et al. Vein of Galen aneurysmal malformation in newborns: a retrospective study to describe a paradigm of treatment and identify risk factors of adverse outcome in a referral center. Front Pediatr. 2023; 11: 1193738.
  16. Sinkovskaya E, Abuhamad A, Horton S, et al. Fetal left brachiocephalic vein in normal and abnormal conditions. Ultrasound Obstet Gynecol. 2012; 40(5): 542–548.
  17. Wojtowicz A, Huras H. Fetal upper mediastinum - normal and abnormal findings in obstetric ultrasound screening. Ginekol Pol. 2020; 91(10): 620–628.
  18. Arko L, Lambrych M, Montaser A, et al. Fetal and Neonatal MRI Predictors of Aggressive Early Clinical Course in Vein of Galen Malformation. AJNR Am J Neuroradiol. 2020; 41(6): 1105–1111.
  19. Berenstein A, Fifi JT, Niimi Y, et al. Vein of Galen malformations in neonates: new management paradigms for improving outcomes. Neurosurgery. 2012; 70(5): 1207–13; discussion 1213.
  20. Orbach DB, Wilkins-Haug LE, Benson CB, et al. Transuterine Ultrasound-Guided Fetal Embolization of Vein of Galen Malformation, Eliminating Postnatal Pathophysiology. Stroke. 2023; 54(6): e231–e232.
  21. Naggara O, Stirnemann J, Boulouis G, et al. Prenatal treatment of a vein of Galen malformation by embolization and 1-year follow-up. Am J Obstet Gynecol. 2024; 230(3): 372–374.